Evidence map›Paper›PMID 37932286›Full record

ArticleNature communications2023

Author Correction: Mutant p53 sustains serine-glycine synthesis and essential amino acids intake promoting breast cancer growth.

Camilla Tombari, Alessandro Zannini, Rebecca Bertolio, Silvia Pedretti, Matteo Audano, Luca Triboli, Valeria Cancila, Davide Vacca, Manuel Caputo, Sara Donzelli and 12 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Nature communications, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

22 authors.

Camilla Tombari *Department of Life Sciences, University of Trieste, 34127, Trieste, Italy.
Alessandro Zannini *Department of Life Sciences, University of Trieste, 34127, Trieste, Italy.
Rebecca BertolioDepartment of Life Sciences, University of Trieste, 34127, Trieste, Italy.ORCID http://orcid.org/0000-0001-5451-7820
Silvia PedrettiDiSFeB, Dipartimento di Scienze Farmacologiche e Biomolecolari, University of Milan, Milan, Italy.ORCID http://orcid.org/0000-0001-6404-6321
Matteo AudanoDiSFeB, Dipartimento di Scienze Farmacologiche e Biomolecolari, University of Milan, Milan, Italy.
Luca TriboliDepartment of Life Sciences, University of Trieste, 34127, Trieste, Italy.
Valeria CancilaTumor Immunology Unit, Department of Health Science, Human Pathology Section, School of Medicine, University of Palermo, 90133, Palermo, Italy.
Davide VaccaTumor Immunology Unit, Department of Health Science, Human Pathology Section, School of Medicine, University of Palermo, 90133, Palermo, Italy.
Manuel CaputoDepartment of Life Sciences, University of Trieste, 34127, Trieste, Italy.
Sara DonzelliTranslational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.ORCID http://orcid.org/0000-0002-8529-2895
Ilenia SegattoUnit of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, 33081, Aviano, Italy.
Simone VodretInternational Centre for Genetic Engineering and Biotechnology (ICGEB), Area Science Park-Padriciano, 34149, Trieste, Italy.
Silvano PiazzaInternational Centre for Genetic Engineering and Biotechnology (ICGEB), Area Science Park-Padriciano, 34149, Trieste, Italy.
Alessandra RustighiDepartment of Life Sciences, University of Trieste, 34127, Trieste, Italy.
Fiamma MantovaniDepartment of Life Sciences, University of Trieste, 34127, Trieste, Italy.
Barbara BellettiUnit of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, 33081, Aviano, Italy.ORCID http://orcid.org/0000-0003-2249-0285
Gustavo BaldassarreUnit of Molecular Oncology, Centro di Riferimento Oncologico di Aviano (CRO), IRCCS, National Cancer Institute, 33081, Aviano, Italy.ORCID http://orcid.org/0000-0002-9750-8825
Giovanni BlandinoTranslational Oncology Research Unit, IRCCS Regina Elena National Cancer Institute, Rome, Italy.ORCID http://orcid.org/0000-0002-6970-2241
Claudio TripodoTumor Immunology Unit, Department of Health Science, Human Pathology Section, School of Medicine, University of Palermo, 90133, Palermo, Italy.ORCID http://orcid.org/0000-0002-0821-6231
Silvio BicciatoCenter for Genome Research, University of Modena and Reggio Emilia, 41125, Modena, Italy.ORCID http://orcid.org/0000-0002-1944-7078
Nico MitroDiSFeB, Dipartimento di Scienze Farmacologiche e Biomolecolari, University of Milan, Milan, Italy.ORCID http://orcid.org/0000-0002-5000-3619
Giannino Del SalDepartment of Life Sciences, University of Trieste, 34127, Trieste, Italy. gdelsal@units.it.ORCID http://orcid.org/0000-0003-2185-6003

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID37932286
PMCPMC10628279

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.